Cassava Sciences
ShareCopied to clipboardCassava Sciences is a company. It is a public company in Austin, the United States. It was founded in 1998 and its current CEO is Richard Jon Barry. It is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Austin
- country: United States
- employees: 30 people
- company type: public
- sector: Health Care
- industry: Biotechnology
- foundation year: 1998
- CEO: Richard Jon Barry
- ESG score: 69.43 / 100
See more facts
Extract data
Download datasets about Cassava Sciences:
Dataset of stocks from Cassava Sciences:
Cassava Sciences is one of the companies in the United States, companies in Biotechnology, companies in Health Care, companies in Austin and 3,456,808 companies in our database.
Talking Points
- Cassava Sciences, Inc.
- The Investor Relations website contains information about Cassava Sciences, Inc.'s business for stockholders, potential investors, and financial analysts.
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.